Semaglutide is an FDA-approved appetite suppressant, administered weekly by subcutaneous injection. Semaglutide activates GLP-1 receptors in the brain, which stimulate insulin secretion and reduce glucagon secretion when blood glucose levels are elevated. It also slows the stomach’s process of moving food to the large intestine, causing the stomach to feel “full” longer.
Semaglutide is the only medication to demonstrate weight loss results that are on par with bariatric surgery. Patients report a significantly reduced appetite, as well as fewer sugar cravings.
We may prescribe a compounded version of semaglutide. This formulation incorporates l-carnitine, an amino acid that facilitates the mobilization of fat. Combined into a single injection, these two treatments work synergistically to significantly reduce appetite and metabolize fat.
As with any medication, some patients have reported side effects. These can include nausea, vomiting, diarrhea, abdominal pain, constipation, heartburn, and burping. If you are experiencing side effects, please talk with one of our providers.
The typical copay on semaglutide is $300 to $500, while out-of-pocket costs can range from $1,500 to $3,000 per month. For many people, this is simply out of reach. That’s why we have partnered with an independent supplier to offer cash pricing starting as low as $150 per month…
|SEMAGLUTIDE + L-CARNITINE 10 UNITS (4 INJECTIONS)||$150|
|SEMAGLUTIDE + L-CARNITINE 20 UNITS (4 INJECTIONS)||$175|
|SEMAGLUTIDE + L-CARNITINE 40 UNITS (4 INJECTIONS)||$185|
|SEMAGLUTIDE + L-CARNITINE 70 UNITS (4 INJECTIONS)||$295|
|SEMAGLUTIDE + L-CARNITINE 100 UNITS (4 INJECTIONS)||$325|
We do our best to keep the information on our website current. However, the prices listed are subject to change without notice. For the most accurate and up-to-date pricing information, please contact us.
Semaglutide packages are non-refundable and expire 40 days after the date of purchase. No exceptions.
Semaglutide/L-carnitine is a compounded medication manufactured for individual patients by Compounding Pharmacy of America and distributed lawfully through OVYVO Medical Weight Loss.
While the Food and Drug Administration (FDA) has not endorsed the combination of semaglutide and l-carnitine, they have approved the use of semaglutide as a standalone medication for the management of excess weight and obesity. L-carnitine, classified as a supplement, is permitted for use in weight loss and various other applications. However, it should be noted that the FDA does not undertake the responsibility of reviewing or approving supplements. This policy also extends to compounded medications which do not fall under the purview of the FDA’s approval process. The production of these compounded medications is regulated by other authoritative bodies.